research Successful treatment of alopecia universalis with abrocitinib: a case report 19 citations , August 2023 in “Journal of Dermatological Treatment” Abrocitinib may effectively treat stubborn alopecia universalis.
research A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib 11 citations , February 2022 in “JAAD case reports” Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.
research Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis 10 citations , September 2024 in “Life” Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.
research Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study 4 citations , October 2024 in “Journal of the American Academy of Dermatology” Abrocitinib may help treat alopecia areata effectively with mild side effects.
research Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib 3 citations , June 2023 in “Journal of cosmetic dermatology” A new drug, abrocitinib, helped a child with severe hair loss regrow hair.
learn Baricitinib JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases